Alexander B Pine, MD PhD1*, Eun-Ju Lee, MD2, Mikkael A. Sekeres, MD, MS3,4, David P. Steensma, MD5, Thomas Prebet, MD6, Amy E. DeZern, MD, MHS7, Rami S. Komrokji, MD8, Mark R Litzow, MD9, Selina Luger, MD10, Richard M. Stone, MD11, Harry P. Erba, MD, PhD12, Guillermo Garcia-Manero, MD13, Alfred I Lee, MD, PhD6*, Nikolai A. Podoltsev, MD, PhD6, Lisa Barbarotta, APRN-BC6*, Jeanne E. Hendrickson, MD14, Steven D. Gore, MD15 and Amer M. Zeidan, MBBS, MHS15
1Yale New Haven Hospital, New Haven, CT
2Hematology, Yale University School of Medicine, New Haven, CT
3Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
4Leukemia Program, Cleveland Clinic, Cleveland, OH
5Dana-Farber Cancer Institute, Boston, MA
6Dept of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
7The Johns Hopkins School of Medicine, Baltimore, MD
8H. Lee Moffitt Cancer Center, Tampa, FL
9Division of Hematology, Mayo Clinic, Rochester, MN
10Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
11Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
12Internal Medicine, Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
13Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
14Laboratory Medicine, Yale University School of Medicine, New Haven, CT
15Yale University School of Medicine, New Haven, CT